1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Skin Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Medicated Creams and Ointments 1.2.3 Antibiotics 1.2.4 Vitamins and Steroids 1.2.5 Antihistamines 1.2.6 Laser Therapy 1.2.7 Antifungals 1.2.8 Others 1.3 Market by Application 1.3.1 Global Skin Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Dermatology Clinics 1.3.3 Skincare Clinics 1.3.4 Hospitals 1.3.5 Aesthetic Centers 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Skin Disease Treatment Market Perspective (2016-2027) 2.2 Skin Disease Treatment Growth Trends by Regions 2.2.1 Skin Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Skin Disease Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Skin Disease Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Skin Disease Treatment Industry Dynamic 2.3.1 Skin Disease Treatment Market Trends 2.3.2 Skin Disease Treatment Market Drivers 2.3.3 Skin Disease Treatment Market Challenges 2.3.4 Skin Disease Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Skin Disease Treatment Players by Revenue 3.1.1 Global Top Skin Disease Treatment Players by Revenue (2016-2021) 3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Skin Disease Treatment Revenue 3.4 Global Skin Disease Treatment Market Concentration Ratio 3.4.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2020 3.5 Skin Disease Treatment Key Players Head office and Area Served 3.6 Key Players Skin Disease Treatment Product Solution and Service 3.7 Date of Enter into Skin Disease Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Skin Disease Treatment Breakdown Data by Type 4.1 Global Skin Disease Treatment Historic Market Size by Type (2016-2021) 4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2022-2027) 5 Skin Disease Treatment Breakdown Data by Application 5.1 Global Skin Disease Treatment Historic Market Size by Application (2016-2021) 5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Skin Disease Treatment Market Size (2016-2027) 6.2 North America Skin Disease Treatment Market Size by Type 6.2.1 North America Skin Disease Treatment Market Size by Type (2016-2021) 6.2.2 North America Skin Disease Treatment Market Size by Type (2022-2027) 6.2.3 North America Skin Disease Treatment Market Size by Type (2016-2027) 6.3 North America Skin Disease Treatment Market Size by Application 6.3.1 North America Skin Disease Treatment Market Size by Application (2016-2021) 6.3.2 North America Skin Disease Treatment Market Size by Application (2022-2027) 6.3.3 North America Skin Disease Treatment Market Size by Application (2016-2027) 6.4 North America Skin Disease Treatment Market Size by Country 6.4.1 North America Skin Disease Treatment Market Size by Country (2016-2021) 6.4.2 North America Skin Disease Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Skin Disease Treatment Market Size (2016-2027) 7.2 Europe Skin Disease Treatment Market Size by Type 7.2.1 Europe Skin Disease Treatment Market Size by Type (2016-2021) 7.2.2 Europe Skin Disease Treatment Market Size by Type (2022-2027) 7.2.3 Europe Skin Disease Treatment Market Size by Type (2016-2027) 7.3 Europe Skin Disease Treatment Market Size by Application 7.3.1 Europe Skin Disease Treatment Market Size by Application (2016-2021) 7.3.2 Europe Skin Disease Treatment Market Size by Application (2022-2027) 7.3.3 Europe Skin Disease Treatment Market Size by Application (2016-2027) 7.4 Europe Skin Disease Treatment Market Size by Country 7.4.1 Europe Skin Disease Treatment Market Size by Country (2016-2021) 7.4.2 Europe Skin Disease Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Skin Disease Treatment Market Size (2016-2027) 8.2 Asia-Pacific Skin Disease Treatment Market Size by Type 8.2.1 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Skin Disease Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Skin Disease Treatment Market Size by Application 8.3.1 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Skin Disease Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Skin Disease Treatment Market Size by Region 8.4.1 Asia-Pacific Skin Disease Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Skin Disease Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Skin Disease Treatment Market Size (2016-2027) 9.2 Latin America Skin Disease Treatment Market Size by Type 9.2.1 Latin America Skin Disease Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Skin Disease Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Skin Disease Treatment Market Size by Type (2016-2027) 9.3 Latin America Skin Disease Treatment Market Size by Application 9.3.1 Latin America Skin Disease Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Skin Disease Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Skin Disease Treatment Market Size by Application (2016-2027) 9.4 Latin America Skin Disease Treatment Market Size by Country 9.4.1 Latin America Skin Disease Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Skin Disease Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Skin Disease Treatment Market Size (2016-2027) 10.2 Middle East & Africa Skin Disease Treatment Market Size by Type 10.2.1 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Skin Disease Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Skin Disease Treatment Market Size by Application 10.3.1 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Skin Disease Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Skin Disease Treatment Market Size by Country 10.4.1 Middle East & Africa Skin Disease Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Skin Disease Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 APEIRON Biologics AG 11.1.1 APEIRON Biologics AG Company Details 11.1.2 APEIRON Biologics AG Business Overview 11.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction 11.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2016-2021) 11.1.5 APEIRON Biologics AG Recent Development 11.2 HanAll BioPharma 11.2.1 HanAll BioPharma Company Details 11.2.2 HanAll BioPharma Business Overview 11.2.3 HanAll BioPharma Skin Disease Treatment Introduction 11.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2016-2021) 11.2.5 HanAll BioPharma Recent Development 11.3 GlaxoSmithKline plc. 11.3.1 GlaxoSmithKline plc. Company Details 11.3.2 GlaxoSmithKline plc. Business Overview 11.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction 11.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2016-2021) 11.3.5 GlaxoSmithKline plc. Recent Development 11.4 Allergen, Plc. 11.4.1 Allergen, Plc. Company Details 11.4.2 Allergen, Plc. Business Overview 11.4.3 Allergen, Plc. Skin Disease Treatment Introduction 11.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2016-2021) 11.4.5 Allergen, Plc. Recent Development 11.5 Anacor Pharmaceuticals 11.5.1 Anacor Pharmaceuticals Company Details 11.5.2 Anacor Pharmaceuticals Business Overview 11.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction 11.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) 11.5.5 Anacor Pharmaceuticals Recent Development 11.6 Celgene 11.6.1 Celgene Company Details 11.6.2 Celgene Business Overview 11.6.3 Celgene Skin Disease Treatment Introduction 11.6.4 Celgene Revenue in Skin Disease Treatment Business (2016-2021) 11.6.5 Celgene Recent Development 11.7 Basilea Pharmaceutica 11.7.1 Basilea Pharmaceutica Company Details 11.7.2 Basilea Pharmaceutica Business Overview 11.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction 11.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2016-2021) 11.7.5 Basilea Pharmaceutica Recent Development 11.8 Cipher Pharmaceuticals 11.8.1 Cipher Pharmaceuticals Company Details 11.8.2 Cipher Pharmaceuticals Business Overview 11.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction 11.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) 11.8.5 Cipher Pharmaceuticals Recent Development 11.9 Agenus 11.9.1 Agenus Company Details 11.9.2 Agenus Business Overview 11.9.3 Agenus Skin Disease Treatment Introduction 11.9.4 Agenus Revenue in Skin Disease Treatment Business (2016-2021) 11.9.5 Agenus Recent Development 11.10 Astion Pharma A/S 11.10.1 Astion Pharma A/S Company Details 11.10.2 Astion Pharma A/S Business Overview 11.10.3 Astion Pharma A/S Skin Disease Treatment Introduction 11.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2016-2021) 11.10.5 Astion Pharma A/S Recent Development 11.11 Bristol-Myers Squibb 11.11.1 Bristol-Myers Squibb Company Details 11.11.2 Bristol-Myers Squibb Business Overview 11.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction 11.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2016-2021) 11.11.5 Bristol-Myers Squibb Recent Development 11.12 Almirall S.A. 11.12.1 Almirall S.A. Company Details 11.12.2 Almirall S.A. Business Overview 11.12.3 Almirall S.A. Skin Disease Treatment Introduction 11.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2016-2021) 11.12.5 Almirall S.A. Recent Development 11.13 Galderma 11.13.1 Galderma Company Details 11.13.2 Galderma Business Overview 11.13.3 Galderma Skin Disease Treatment Introduction 11.13.4 Galderma Revenue in Skin Disease Treatment Business (2016-2021) 11.13.5 Galderma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Skin Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Medicated Creams and Ointments Table 3. Key Players of Antibiotics Table 4. Key Players of Vitamins and Steroids Table 5. Key Players of Antihistamines Table 6. Key Players of Laser Therapy Table 7. Key Players of Antifungals Table 8. Key Players of Others Table 9. Global Skin Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Skin Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Skin Disease Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Skin Disease Treatment Market Share by Regions (2016-2021) Table 13. Global Skin Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Skin Disease Treatment Market Share by Regions (2022-2027) Table 15. Skin Disease Treatment Market Trends Table 16. Skin Disease Treatment Market Drivers Table 17. Skin Disease Treatment Market Challenges Table 18. Skin Disease Treatment Market Restraints Table 19. Global Skin Disease Treatment Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Skin Disease Treatment Market Share by Players (2016-2021) Table 21. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2020) Table 22. Ranking of Global Top Skin Disease Treatment Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Skin Disease Treatment Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Skin Disease Treatment Product Solution and Service Table 26. Date of Enter into Skin Disease Treatment Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million) Table 29. Global Skin Disease Treatment Revenue Market Share by Type (2016-2021) Table 30. Global Skin Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Skin Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Skin Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Skin Disease Treatment Revenue Market Share by Application (2016-2021) Table 34. Global Skin Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Skin Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million) Table 37. North America Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million) Table 39. North America Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Skin Disease Treatment Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Skin Disease Treatment Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 66. APEIRON Biologics AG Company Details Table 67. APEIRON Biologics AG Business Overview Table 68. APEIRON Biologics AG Skin Disease Treatment Product Table 69. APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 70. APEIRON Biologics AG Recent Development Table 71. HanAll BioPharma Company Details Table 72. HanAll BioPharma Business Overview Table 73. HanAll BioPharma Skin Disease Treatment Product Table 74. HanAll BioPharma Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 75. HanAll BioPharma Recent Development Table 76. GlaxoSmithKline plc. Company Details Table 77. GlaxoSmithKline plc. Business Overview Table 78. GlaxoSmithKline plc. Skin Disease Treatment Product Table 79. GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 80. GlaxoSmithKline plc. Recent Development Table 81. Allergen, Plc. Company Details Table 82. Allergen, Plc. Business Overview Table 83. Allergen, Plc. Skin Disease Treatment Product Table 84. Allergen, Plc. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 85. Allergen, Plc. Recent Development Table 86. Anacor Pharmaceuticals Company Details Table 87. Anacor Pharmaceuticals Business Overview Table 88. Anacor Pharmaceuticals Skin Disease Treatment Product Table 89. Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 90. Anacor Pharmaceuticals Recent Development Table 91. Celgene Company Details Table 92. Celgene Business Overview Table 93. Celgene Skin Disease Treatment Product Table 94. Celgene Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 95. Celgene Recent Development Table 96. Basilea Pharmaceutica Company Details Table 97. Basilea Pharmaceutica Business Overview Table 98. Basilea Pharmaceutica Skin Disease Treatment Product Table 99. Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 100. Basilea Pharmaceutica Recent Development Table 101. Cipher Pharmaceuticals Company Details Table 102. Cipher Pharmaceuticals Business Overview Table 103. Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 104. Cipher Pharmaceuticals Recent Development Table 105. Agenus Company Details Table 106. Agenus Business Overview Table 107. Agenus Skin Disease Treatment Product Table 108. Agenus Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 109. Agenus Recent Development Table 110. Astion Pharma A/S Company Details Table 111. Astion Pharma A/S Business Overview Table 112. Astion Pharma A/S Skin Disease Treatment Product Table 113. Astion Pharma A/S Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 114. Astion Pharma A/S Recent Development Table 115. Bristol-Myers Squibb Company Details Table 116. Bristol-Myers Squibb Business Overview Table 117. Bristol-Myers Squibb Skin Disease Treatment Product Table 118. Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 119. Bristol-Myers Squibb Recent Development Table 120. Almirall S.A. Company Details Table 121. Almirall S.A. Business Overview Table 122. Almirall S.A. Skin Disease Treatment Product Table 123. Almirall S.A. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 124. Almirall S.A. Recent Development Table 125. Galderma Company Details Table 126. Galderma Business Overview Table 127. Galderma Skin Disease Treatment Product Table 128. Galderma Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million) Table 129. Galderma Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global Skin Disease Treatment Market Share by Type: 2020 VS 2027 Figure 2. Medicated Creams and Ointments Features Figure 3. Antibiotics Features Figure 4. Vitamins and Steroids Features Figure 5. Antihistamines Features Figure 6. Laser Therapy Features Figure 7. Antifungals Features Figure 8. Others Features Figure 9. Global Skin Disease Treatment Market Share by Application: 2020 VS 2027 Figure 10. Dermatology Clinics Case Studies Figure 11. Skincare Clinics Case Studies Figure 12. Hospitals Case Studies Figure 13. Aesthetic Centers Case Studies Figure 14. Others Case Studies Figure 15. Skin Disease Treatment Report Years Considered Figure 16. Global Skin Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Skin Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Skin Disease Treatment Market Share by Regions: 2020 VS 2027 Figure 19. Global Skin Disease Treatment Market Share by Regions (2022-2027) Figure 20. Global Skin Disease Treatment Market Share by Players in 2020 Figure 21. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Skin Disease Treatment Revenue in 2020 Figure 23. Global Skin Disease Treatment Revenue Market Share by Type (2016-2021) Figure 24. Global Skin Disease Treatment Revenue Market Share by Type (2022-2027) Figure 25. North America Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Skin Disease Treatment Market Share by Type (2016-2027) Figure 27. North America Skin Disease Treatment Market Share by Application (2016-2027) Figure 28. North America Skin Disease Treatment Market Share by Country (2016-2027) Figure 29. United States Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Skin Disease Treatment Market Share by Type (2016-2027) Figure 33. Europe Skin Disease Treatment Market Share by Application (2016-2027) Figure 34. Europe Skin Disease Treatment Market Share by Country (2016-2027) Figure 35. Germany Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Skin Disease Treatment Market Share by Type (2016-2027) Figure 43. Asia-Pacific Skin Disease Treatment Market Share by Application (2016-2027) Figure 44. Asia-Pacific Skin Disease Treatment Market Share by Region (2016-2027) Figure 45. China Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Skin Disease Treatment Market Share by Type (2016-2027) Figure 53. Latin America Skin Disease Treatment Market Share by Application (2016-2027) Figure 54. Latin America Skin Disease Treatment Market Share by Country (2016-2027) Figure 55. Mexico Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Skin Disease Treatment Market Share by Type (2016-2027) Figure 59. Middle East & Africa Skin Disease Treatment Market Share by Application (2016-2027) Figure 60. Middle East & Africa Skin Disease Treatment Market Share by Country (2016-2027) Figure 61. Turkey Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. APEIRON Biologics AG Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 65. HanAll BioPharma Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 66. GlaxoSmithKline plc. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 67. Allergen, Plc. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 68. Anacor Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 69. Celgene Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 70. Basilea Pharmaceutica Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 71. Cipher Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 72. Agenus Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 73. Astion Pharma A/S Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 75. Almirall S.A. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 76. Galderma Revenue Growth Rate in Skin Disease Treatment Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

APEIRON Biologics AG HanAll BioPharma GlaxoSmithKline plc. Allergen, Plc. Anacor Pharmaceuticals Celgene Basilea Pharmaceutica Cipher Pharmaceuticals Agenus Astion Pharma A/S Bristol-Myers Squibb Almirall S.A. Galderma